Cytosorbents Corporation (CTSO): Price and Financial Metrics
CTSO Price/Volume Stats
| Current price | $1.06 | 52-week high | $1.61 |
| Prev. close | $1.05 | 52-week low | $0.70 |
| Day low | $1.02 | Volume | 62,500 |
| Day high | $1.06 | Avg. volume | 184,762 |
| 50-day MA | $0.96 | Dividend yield | N/A |
| 200-day MA | $1.03 | Market Cap | 66.37M |
CTSO Stock Price Chart Interactive Chart >
Cytosorbents Corporation (CTSO) Company Bio
CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.
CTSO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CTSO Price Returns
| 1-mo | 21.84% |
| 3-mo | 4.95% |
| 6-mo | 20.43% |
| 1-year | 19.37% |
| 3-year | -56.91% |
| 5-year | -88.33% |
| YTD | 16.48% |
| 2024 | -18.02% |
| 2023 | -28.39% |
| 2022 | -63.01% |
| 2021 | -47.43% |
| 2020 | 107.01% |